A. Altinova Et Al. , "Serum IL-18 levels in patients with type 1 diabetes: Relations to metabolic control and microvascular complications," CYTOKINE , vol.42, no.2, pp.217-221, 2008
Altinova, A. Et Al. 2008. Serum IL-18 levels in patients with type 1 diabetes: Relations to metabolic control and microvascular complications. CYTOKINE , vol.42, no.2 , 217-221.
Altinova, A., YETKİN, İ., AKBAY, E., BUKAN, N., & Arslan, M., (2008). Serum IL-18 levels in patients with type 1 diabetes: Relations to metabolic control and microvascular complications. CYTOKINE , vol.42, no.2, 217-221.
Altinova, ALEV Et Al. "Serum IL-18 levels in patients with type 1 diabetes: Relations to metabolic control and microvascular complications," CYTOKINE , vol.42, no.2, 217-221, 2008
Altinova, ALEV E. Et Al. "Serum IL-18 levels in patients with type 1 diabetes: Relations to metabolic control and microvascular complications." CYTOKINE , vol.42, no.2, pp.217-221, 2008
Altinova, A. Et Al. (2008) . "Serum IL-18 levels in patients with type 1 diabetes: Relations to metabolic control and microvascular complications." CYTOKINE , vol.42, no.2, pp.217-221.
@article{article, author={ALEV EROĞLU ALTINOVA Et Al. }, title={Serum IL-18 levels in patients with type 1 diabetes: Relations to metabolic control and microvascular complications}, journal={CYTOKINE}, year=2008, pages={217-221} }